论文部分内容阅读
目的:探讨对重症胰腺炎(SAP)并发胃肠麻痹患者采用新斯的明联合清胰汤治疗的临床效果。方法:收集48例SAP并发胃肠麻痹患者的临床资料,分为观察组(足三里注射新斯的明联合清胰汤治疗)与对照组(常规治疗),各24例。结果:观察组患者治疗的总有效率为95.83%,显著高于对照组的75.00%,有统计学意义(P<0.05);观察组的首次排便时间、腹痛持续时间、血淀粉酶升高持续时间、血钙恢复正常时间及ICU住院时间、均显著短于对照组,有统计学意义(P<0.05)。结论:对SAP并发胃肠麻痹患者采用足三里注射新斯的明联合清胰汤治疗,能快速、有效促进患者的恢复,疗效显著,值得推广。
Objective: To investigate the clinical effect of neostigmine combined Qingyitang in patients with severe pancreatitis (SAP) complicated with gastrointestinal paralysis. Methods: The clinical data of 48 patients with SAP complicated with gastrointestinal paralysis were collected and divided into observation group (treated with injection of Neostigmine combined with Qingyao decoction of Zusanli) and control group (routine treatment), 24 cases in each group. Results: The total effective rate of observation group was 95.83%, which was significantly higher than that of control group (75.00%, P <0.05). The first defecation time, the duration of abdominal pain and the increase of blood amylase in the observation group continued Time, serum calcium recovery time and ICU hospitalization were significantly shorter than the control group, with statistical significance (P <0.05). Conclusion: The treatment of patients with SAP complicated with gastrointestinal paralysis by injection of Neostigmine in combination with Qingyao decoction can rapidly and effectively promote the recovery of patients with significant curative effect and worthy of promotion.